Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3488 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 16 17 18 ... 33 34 35  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Hummingbird Bioscience–SEVERAL: investment, 202105 financing round Series C $125m led by Novo Holdings 2021-05-18
Immunodiagnostic Systems–PerkinElmer: investment, 202105– recommended all cash offer £110m by PerkinElmer ANNOUNCED 2021-05-17
Soteria Biotherapeutics–Merck (DE): investment, 202105 financing round Series A totalling $42m incl co-investor M Ventures 2021-05-17
Soteria Biotherapeutics–Novartis: investment, 202105 financing round Series A totalling $42m incl co-investor Novartis Venture Fund 2021-05-17
Soteria Biotherapeutics–Roche: investment, 202105 financing round Series A totalling $42m incl co-lead investor Roche Venture Fund 2021-05-17
Soteria Biotherapeutics–SEVERAL: investment, 202105 financing round Series A $42m co-led by Roche Venture Fund + 5AM Ventures 2021-05-17
Flare Therapeutics–Nextech: investment, 202105 financing round Series A totalling $82m incl co-investor Nextech Invest 2021-05-13
Flare Therapeutics–SEVERAL: investment, 202105 financing round Series A $82m led by Third Rock Ventures 2021-05-13
Biocatalysts Ltd–BRAIN Biotech: investment, 202105 acquisition addit 16.7% for £3.9m bringing total to 82.2% with 2 put options excercised 2021-05-12
AMSilk–Cargill: investment, 202105 financing round Series C totalling €29m incl new + co-investor Cargill 2021-05-11
AMSilk–ER Capital Holdings: investment, 202105 financing round Series C totalling €29m incl new + co-investor ER Capital Holdings 2021-05-11
AMSilk–MIG Fonds: investment, 202105 financing round Series C totalling €29m incl existing + co-investor MIG Verwaltungs AG 2021-05-11
AMSilk–Novo Group: investment, 202105 financing round Series C totalling €29m incl new + lead investor Novo Growth 2021-05-11
AMSilk–SEVERAL: investment, 202105 financing round Series C €29m led by Novo Growth with Cargill + ER Capital Holdings + MIG AG + Athos KG 2021-05-11
AMSilk–Strüngmann Group: investment, 202105 financing round Series C totalling €29m incl existing + co-investor Athos KG 2021-05-11
Abingworth–SEVERAL: investment, 202105 final closing at $582m of Abingworth Clinical Co-Development Fund 2 2021-05-10
BioNTech–Singapore (govt): grant, 202105– support from Singapore EDB for planned mRNA-based vaccine + therapeutics manufacturing plant in Singapore 2021-05-10
Cellares–SEVERAL: investment, 202105 financing round Series B $82m led by Decheng Capital + Eclipse Ventures 2021-05-05
Cellares–Skyviews Life Science: investment, 202105 financing round Series B totalling $82m incl new + co-investor Skyviews Life Science 2021-05-05
Cytoki Pharma–+ND Capital: investment, 202105 financing round Series A totalling $45m incl co-investor +ND Captial 2021-05-05
Cytoki Pharma–SEVERAL: investment, 202105 financing round Series A $45m led by existing investor Lundbeckfonden Emerge 2021-05-05
Cytoki Pharma–Ysios Capital: investment, 202105 financing round Series A totalling $45m incl co-investor Ysios Capital 2021-05-05
APR Applied Pharma Research–Relief Therapeutics: investment, 202105– acquisition for CHF22m cash + CHF50m in shares binding term sheet signed 2021-05-04
ITM–Trophic Communications: public relations, 202105 service existent by Trophic Communications 2021-05-04
Labforward–Berlin (govt): investment, 202105 financing round Series B 2nd closing totalling >€3m incl existing + co-investor IBB Ventures 2021-05-04
Labforward–Fielmann Group: investment, 202105 financing round Series B 2nd closing totalling >€3m incl new + lead investor Fielmann Family Office 2021-05-04
Labforward–OTHER: investment, 202105 financing round Series B 2nd closing totalling >€3m incl existing + new business angels 2021-05-04
Labforward–SEVERAL: investment, 202105 financing round Series B 2nd closing >€3m led by Fielmann Family Office bringing total Series B to >€8.5m 2021-05-04
Oculis–BVCF Management: investment, 202105 financing round Series C totalling $57m incl new + co-lead investor BVCF Management 2021-05-04
Oculis–Hyfinity Investments: investment, 202105 financing round Series C totalling $57m incl new + co-lead investor Hyfinity Investments 2021-05-04
Oculis–SEVERAL: investment, 202105 financing round Series C $57m co-led by new investors BVCF Management + Hyfinity Investments 2021-05-04
Alto Neuroscience–Angermayer Group: investment, 202105 financing round Series A totalling $32m incl lead investor Apeiron Investment Group 2021-05-03
Alto Neuroscience–SEVERAL: investment, 202105 financing round Series A $32m with lead investor Apeiron Investment Group 2021-05-03
Celeris Therapeutics–Austria (govt): grant, 202105 grant €600k from aws 2021-05-03
MoonLake–BVF Partners: investment, 202105c financing round Series A incl lead investor BVF Partners 2021-05-03
MoonLake–Merck (DE): investment, 202105c financing round Series A incl co-investor Merck KGaA 2021-05-03
MoonLake–Merck (DE): sonelokimab, 202105– license from Merck KGaA 2021-05-03
MoonLake–Mo PR Advisory: public relations, 202105 service existent by Mo PR Advisory 2021-05-03
MoonLake–SEVERAL: investment, 202105c financing round Series A led by BVF Partners + incl Merck KGaA 2021-05-03
Aquila Biolabs–Scientific Industries: investment, 202104 acquisition of Aquila Biolabs GmbH by Scientific Bioprocessing Inc 2021-04-30
Valneva–SEVERAL: investment, 202104–202105 European private placement €26.895m with 2.445m ordinary shares at €11/share 2021-04-29
Valneva–SEVERAL: investment, 202104–202105 US IPO $61.24m+$14m with 2.32m+531k ADSs at $26.41/ADS as Nasdaq Global Select Market 2021-04-29
Boundless Bio–Nextech: investment, 202104 financing round Series B totalling $105m incl new + co-lead investor Nextech Invest 2021-04-28
Boundless Bio–SEVERAL: investment, 202104 financing round Series B $105m co-led by Nextech Invest + RA Capital Management 2021-04-28
Kaia Health–3VC: investment, 202104 financing round Series C totalling $75m incl existing + co-investor 3VC 2021-04-28
Kaia Health–A Round Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor A Round Capital 2021-04-28
Kaia Health–Balderton Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Balderton Capital 2021-04-28
Kaia Health–Eurazeo: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Eurazeo 2021-04-28
Kaia Health–Heartcore Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Heartcore Capital 2021-04-28
Kaia Health–Hot Cherry PR: public relations, 202104 service existent by Hot Cherry PR 2021-04-28
Kaia Health–OTHER: investment, 202104 financing round Series C totalling $75m incl undisclosed growth equity fund as lead investor 2021-04-28
Kaia Health–SEVERAL: investment, 202104 financing round Series C $75m led by undisclosed growth equity fund 2021-04-28
Kaia Health–Symphony Ventures: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Symphony Ventures 2021-04-28
Kaia Health–UnitedHealth: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Optum Ventures 2021-04-28
Exciva–Andera Partners: investment, 202104 existent investment of Andera Partners 2021-04-27
PreComb Therapeutics–FiveT Capital: investment, 202104 seed financing round totalling CHF2.2m incl co-lead investor FiveT Capital 2021-04-26
PreComb Therapeutics–High-Tech Gründerfonds: investment, 202104 seed financing round totalling CHF2.2m incl co-lead investor HTGF 2021-04-26
PreComb Therapeutics–Kinled: investment, 202104 seed financing round totalling CHF2.2m incl co-lead investor Kinled Austria 2021-04-26
PreComb Therapeutics–SEVERAL: investment, 202104 seed financing round CHF2.2m led by Kinled Austria + HTGF + FiveT Capital 2021-04-26
Molecular Partners–SEVERAL: investment, 202104–202106 US IPO $63.75m+$9.56m with 3m+450k ADSs at $21.25/ADS at Nasdaq 2021-04-23
NLC Ventures–SEVERAL: investment, 202104 financing round €20m from family offices across Europe 2021-04-23
Anavo Therapeutics–MacDougall Advisors: public relations, 202104 service existent by MacDougall 2021-04-22
Anavo Therapeutics–Merck (DE): investment, 202104 seed financing round totalling €20m incl co-lead investor M Ventures 2021-04-22
Anavo Therapeutics–SEVERAL: investment, 202104 seed financing round €20m led by M Ventures + Inkef Capital 2021-04-22
CeQur–Endeavour Vision: investment, 202104 investment existent by EMG II Fund 2021-04-22
Deep Instinct–SEVERAL: investment, 202104 financing round Series D $100m led by funds + accounts managed by BlackRock 2021-04-22
Endeavour Vision–SEVERAL: investment, 202104 closing of Endeavour Medtech Growth II fund at $375m 2021-04-22
IntelyCare–Endeavour Vision: investment, 202104 investment existent by EMG II Fund 2021-04-22
ITM–Petrichor Healthcare: credit, 202104– convertible loan financing totalling €90m led by Petrichor HCM 2021-04-22
ITM–SEVERAL: credit, 202104– convertible loan financing €90m led by Petrichor HCM with undisclosed other investors 2021-04-22
Lumeon–Endeavour Vision: investment, 202104 investment existent by EMG II Fund 2021-04-22
Nalu Medical–Endeavour Vision: investment, 202104 investment existent by EMG II Fund 2021-04-22
Rapid Micro Biosystems–Endeavour Vision: investment, 202104 investment existent by EMG II Fund 2021-04-22
Relievant Medsystems–Endeavour Vision: investment, 202104 investment existent by EMG II Fund 2021-04-22
Atriva Therapeutics–Germany (govt): grant, 202104– up to €11.4m research funding from BMBF to advance ATR-002 for Covid-19 2021-04-21
OxVax–Evotec: investment, 202104 seed financing round totalling €na incl co-lead investor Evotec 2021-04-21
OxVax–SEVERAL: investment, 202104 seed financing round €na from Lead Compass Investment + Evotec 2021-04-21
Forbion–SEVERAL: investment, 202104 additional €175m + final closing at hard cap of €360m of Forbion Growth Opportunities Fund I 2021-04-20
Rinri Therapeutics–Boehringer: investment, 202104 financing round totalling £10m incl existing investor BIVF 2021-04-20
Rinri Therapeutics–SEVERAL: investment, 202104 financing round £10m from existing investors + incl convertible loan from UK Future Fund 2021-04-20
Sense Biodetection–Earlybird: investment, 202104 financing round Series B totalling $50m incl exisiting + co-investor Earlybird Health 2021-04-20
Sense Biodetection–SEVERAL: investment, 202104 financing round Series B $50m led by Koch Disruptive Technologies 2021-04-20
Synendos Therapeutics–Ysios Capital: investment, 202104 investment by new investor Ysios Capital extends financing round Series A to CHF24m 2021-04-20
BioVersys–EU (govt): credit, 202104– venture debt loan up to €20m in three tranches from EIB 2021-04-14
Quercis Pharma–Rx Communications: public relations, 202104 service existent IR by Rx Communications Group 2021-04-13
Repertoire Immune Medicines–SEVERAL: investment, 202104 financing round Series B $189m incl Flagship Pioneering + Softbank + PSP Investments et al 2021-04-13
Siemens–Biognosys: MS-based biomarker discovery, 202104– strategic agreem marker discovery using HRM-MS for Dx assay development with S Healthineers 2021-04-13
ImmunOs Therapeutics–EU (govt): grant, 202104– Eurostars-2 grant for developm of OCi antibody tog with ProteoGenix SAS + Amsterdam UMC 2021-04-12
Mestex–Grünenthal: investment, 202104 acquisition 100% of Mestex AG by Grünenthal 2021-04-12
VectivBio–SEVERAL: investment, 202104 IPO $127.5m+$19.125m with 7.5m+1.125m ordinary shares at $17/share at Nasdaq Global Market 2021-04-08
Delta 4–OTHER: investment, 202104 financing round Series A €multi-million closing with addit funding from European Family Office 2021-04-07
Delta 4–SEVERAL: investment, 202104 financing round Series A €multi-million closing with addit funding from European Family Office 2021-04-07
Metagenomi–SEVERAL: investment, 202104 financing round Series A extension $10m with RA Capital Management closing total Series A at $75m 2021-04-07
Stimit–Dräger: investment, 202104 acquisition of majority share in Stimit AG by Drägerwerk AG & Co KGaA 2021-04-01
Celeris Therapeutics–Longevitytech.fund: investment, 202103 pre-seed financing round totalling €400k incl investor Longevitytech.fund 2021-03-31
Celeris Therapeutics–R42 Group: investment, 202103 pre-seed financing round totalling €400k incl investor R42 Group 2021-03-31
Celeris Therapeutics–SEVERAL: investment, 202103 pre-seed financing round €400k from R42 Group + Longevitytech.fund 2021-03-31
OncoResponse–Helsinn: investment, 202103 financing round Series C totalling $40.6m incl existing + co-investor 3B Future Health Fund 2021-03-31
OncoResponse–SEVERAL: investment, 202103 financing round Series C $40.6m led by Magnetar Group 2021-03-31
Pyxis Oncology–Bayer: investment, 202103 financing round Series B totalling $152m incl existing + co-investor Leaps by Bayer 2021-03-30
next pagenext page 1 2 3 ... 16 17 18 ... 33 34 35  next pagenext page



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top